Member Info for gemstar

Five fold?

I’m personally looking for 10 fold

BRING IT ON

Disgraceful if true

From ADVFN

“ Losing track here with all the usual twists and turns

Is this the position from LSE?

“say the mine is currently generating $50m pa, VAST receive 49% of that, circa $25m, based on today's commodity prices.

Let us assume the AISC (production cost) is $1850oz for gold, equates to $10m on VAST's 49% share, production cost of silver (usually a by product) £1m, total cost of production (VAST's share) $11m

Based on the above the mine would generate an annual profit on VAST's 49% share of $14m or around £11m

Mug punter 20% = £2.2m

Present value £6.5m

Of course unlike now, 20% mug punter will have no control over where 51% and 80% decide to spend any income. Maybe they decide not to declare dividends for 5 years

All reminiscent of mug punter position with gold mine in Zimbabwe where mug punter had no control over allocation of revenue”

Wyndrum “SGC is a relatively rare and therefore small market.”

I think that is recognised. I thought the company’s point in pursuing SGC is it hopes the US will grant early recognition being no present SOC and thus validate the platform generally

So Wyndrum these results on an untreatable cancer are not good enough?

Throgmorton, I thought all this half life trope of yours had been comprehensively refuted?

Today’s drop, caused by round machine numbers, is usually associated with forward selling

Wyndrum hm

“ Avacta’s recent data demonstrate continued robust and meaningful tumour shrinkage in patients with SGCs and a combined disease control rate of 90% across Phase Ia and Phase Ib patients.

Based on the preliminary favourable efficacy and safety data observed in the Phase Ib cohort in this part of the trial, enrolment will continue in this cohort with further data updates across the Phase Ia and Phase Ib cohorts expected in 1H 2026.

Dr Christina Coughlin, CEO of Avacta, commented: “SGC cancer is a devastating disease with no established standard of care treatment options. The clinically meaningful tumour shrinkage and prolonged progression free survival we have observed in the study highlight faridoxorubicin’s potential as an important new treatment option for patients with SGC and other solid tumours. “

https://www.ddw-online.com/phase-i-trial-shows-90-disease-control-in-salivary-gland-cancers-39642-202512/

Thanks for taking the time for that full answer Wyndrum

Wyndrum you keep saying the data is poor

Could you expand on this a little ?

Apparently the company’s accounts for the company taking 80% is a shocker

And its shareholders there get a way out

And Prelea gets £2m, so it’s all good

I can see Tom sinking his teeth deep into this one

Red meat

What’s the position with the convertible now?

I thought the TNBC idea came from Tempus

“ Not a single concept of intelligence in the whole lot of that”

Too severe

Yes, like the grit in the oyster, there will be little intelligence, but will stimulate debate

HTTps://kalkine.co.uk/news/premium/vast-stock-moonbound-28-surge-signals-massive-zimbabwe-diamond-breakthrough

HTTps://x.com/lewisthetrader/status/2002314962329296933?s=20

VAST Stock Moonbound - 28% Surge Signals Massive Zimbabwe Diamond Breakthrough

Knowledgeable posters now having obliterated Thorogsons half life obsession, I shall assume if he uses the expression half life again that he is just a stirring troll who should be filtered

Having said that, it is a feature of the Mediterranean Male’s brain that he is incapable of ever admitting a mistake. Does your family originate in the Mediterranean area Thorogson? If so, leniency may be in order

“ Phase 1 has not produced the results expected. only partial and minor recordings”

Is this a correct statement?

You’re flailing around a bit now

Your obsession has been dealt with

There is no “ conversation “ to add to it

thornogson thank you for your honesty “a half life of 45 minutes!”

and for confirming that the obsession buzzing around inside your head is just *******s

another poster on here explains to you why

“the plasma half-life is around an hour but is significantly extended in the tumour microenvironment. so again, there is limited circulating drug to cause side effects and it is concentrated into the tumour; the ratio of drug in tumour versus circulating in the blood stream been calculated to be in excess of 100:1. the net result is that it halts tumour growth in patient cases where no other drug has any effect at all.”